Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 2
2016 1
2017 2
2018 4
2019 5
2020 7
2021 5
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Editorial: Estrogen receptors in endocrine disorders.
Filardi T, Townsend KL, Lappano R, Caprio M. Filardi T, et al. Front Endocrinol (Lausanne). 2023 Nov 1;14:1325371. doi: 10.3389/fendo.2023.1325371. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027157 Free PMC article. No abstract available.
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study.
Catanzaro G, Conte F, Trocchianesi S, Splendiani E, Bimonte VM, Mocini E, Filardi T, Po A, Besharat ZM, Gentile MC, Paci P, Morano S, Migliaccio S, Ferretti E. Catanzaro G, et al. Among authors: filardi t. Sci Rep. 2023 Nov 9;13(1):19496. doi: 10.1038/s41598-023-46516-y. Sci Rep. 2023. PMID: 37945677 Free PMC article.
Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, Midulla F, Costantino F, Morano S. Tiberti C, et al. Among authors: filardi t. Acta Diabetol. 2023 Oct;60(10):1309. doi: 10.1007/s00592-023-02152-6. Acta Diabetol. 2023. PMID: 37474814 Free PMC article. No abstract available.
No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, Midulla F, Costantino F, Morano S. Tiberti C, et al. Among authors: filardi t. Acta Diabetol. 2023 Oct;60(10):1301-1307. doi: 10.1007/s00592-023-02103-1. Epub 2023 May 12. Acta Diabetol. 2023. PMID: 37171699 Free PMC article.
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.
Maddaloni E, Coraggio L, Amendolara R, Baroni MG, Cavallo MG, Copetti M, Cossu E, D'Angelo P, D'Onofrio L, Cosmo S, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Park K, Holman RR, Trischitta V, Buzzetti R; SUMMER Study in Diabetes Group. Maddaloni E, et al. Diabetes Metab Res Rev. 2023 Jul;39(5):e3632. doi: 10.1002/dmrr.3632. Epub 2023 Mar 20. Diabetes Metab Res Rev. 2023. PMID: 36880127
44 results